Search research articles
Contact Us
Filters
Showing results (21-30 of 177) with videos related to
Page
of 18
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology
|
November 21, 2007
Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction
Takeshi Soeki, Ichiro Kishimoto, Daryl O Schwenke, et al.
Journal of Atherosclerosis and Thrombosis
|
February 27, 2020
Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice
Arief Rahadian, Daiju Fukuda, Hotimah Masdan Salim, et al.
European Journal of Pharmacology
|
December 23, 2017
Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury
Tomoya Hara, Daiju Fukuda, Kimie Tanaka, et al.
European Journal of Pharmacology
|
March 2, 2020
Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice
Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, et al.
Vascular Pharmacology
|
August 17, 2015
Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice
Hotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.
Vascular Pharmacology
|
November 24, 2019
Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice
Arief Rahadian, Daiju Fukuda, Hotimah Masdan Salim, et al.
Journal of Atherosclerosis and Thrombosis
|
September 4, 2020
Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice
Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, et al.
Vascular Pharmacology
|
March 29, 2017
Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice
Hotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.
European Journal of Pharmacology
|
November 19, 2011
A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury
Yoichiro Hirata, Michio Shimabukuro, Etsuko Uematsu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
July 6, 2012
Renoprotective and antioxidant effects of cilnidipine in hypertensive patients
Takeshi Soeki, Mitsuhiro Kitani, Kenya Kusunose, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 177) with videos related to
Sort By:
Page
of 18
American Journal of Physiology. Heart and Circulatory Physiology
|
November 21, 2007
Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction
Takeshi Soeki, Ichiro Kishimoto, Daryl O Schwenke, et al.
Journal of Atherosclerosis and Thrombosis
|
February 27, 2020
Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice
Arief Rahadian, Daiju Fukuda, Hotimah Masdan Salim, et al.
European Journal of Pharmacology
|
December 23, 2017
Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury
Tomoya Hara, Daiju Fukuda, Kimie Tanaka, et al.
European Journal of Pharmacology
|
March 2, 2020
Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice
Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, et al.
Vascular Pharmacology
|
August 17, 2015
Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice
Hotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.
Vascular Pharmacology
|
November 24, 2019
Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice
Arief Rahadian, Daiju Fukuda, Hotimah Masdan Salim, et al.
Journal of Atherosclerosis and Thrombosis
|
September 4, 2020
Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice
Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, et al.
Vascular Pharmacology
|
March 29, 2017
Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice
Hotimah Masdan Salim, Daiju Fukuda, Yasutomi Higashikuni, et al.
European Journal of Pharmacology
|
November 19, 2011
A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury
Yoichiro Hirata, Michio Shimabukuro, Etsuko Uematsu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
July 6, 2012
Renoprotective and antioxidant effects of cilnidipine in hypertensive patients
Takeshi Soeki, Mitsuhiro Kitani, Kenya Kusunose, et al.
Page
of 18